TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
BNR

Burning Rock Biotech Ltd

Healthcare · Diagnostics & Research

16.00$ -9.3% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow BNR
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – –
– +15.8% +27.1% +6.2% +43.4% +159.8% +7.5% -60.9% -58.3%
– +25.7% +347.3% +660.0% +63.0% +15.7% -20.2% -40.3% -91.1%
– -7.7% +294.4% +368.1% +69.3% +25.9% – – –
– – – – -155.7% – – – –
– +7.4% +85.0% +73.9% +168.4% -70.9% -84.9% -36.3% -12.2%
– – -426.8% -68.5% – -109.1% +24.6% -52.6% -0.5%
– – – – – – – – –
– -83.4% +142.4% -3.7% +22.0% +1,582.3% -90.3% -99.0% -100.0%
– -35.6% -198.4% -74.8% +117.6% -94.7% -100.0% – –
– -76.5% +585.6% +278.8% -102.4% +63.0% -43.4% -99.9% –
– +125.5% -92.8% +62,682.2% -126.6% – – – –
– – – – – – – – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?